| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a tumor antigenic peptide specifically recognized by cytotoxic T lymphocytes injuring cancer cells as HLA-A24 binding, a DNA encoding the same, cytotoxic lymphocytes injuring the cancer cells as HLA-A24 binding, obtained by utilizing the peptide or the DNA encoding the same, a method for inducing the same, and a cancer vaccine containing the tumor antigenic peptide or the DNA encoding the same. <P>SOLUTION: This tumor antigenic peptide consists of an amino acid sequence of NYGFQIHTK (sequence number 1 in the specification). <P>COPYRIGHT: (C)2006,JPO&NCIPI</p> |
